Companies
Sd

Standigm

AI-powered drug discovery and repurposing from Seoul

Founded2015
HQSeoul, South Korea
StageClinical
standigm.com
SharePostShare

Overview

Standigm is a South Korean AI drug discovery company whose ASK platform (AI-based Standigm Knowledge) integrates knowledge graph analysis, molecular generation, and predictive modeling for target identification, hit discovery, and drug repurposing. The company has partnerships with global pharmaceutical companies including Sanofi and SK Biopharmaceuticals, and has filed multiple IND applications.

Focus areas

Target Discovery, Generative Chemistry, Virtual Screening

Key models

ASK


Technology

ASK (AI-based Standigm Knowledge) platform integrates knowledge graph analysis for target identification, generative molecular design for hit discovery, and predictive modeling for ADMET and efficacy optimization. The platform supports both novel drug discovery and repurposing of existing drugs.

Platforms & Tools
ASK (AI-based Standigm Knowledge)Knowledge graphMolecular generation

Partnerships
SanofiAI-driven drug discovery collaboration
SK BiopharmaceuticalsCNS drug discovery collaboration

Similar companies

Get updates on Standigm

We'll notify you when we publish updates about Standigm.